Condition: Autism · Sponsor: Indiana University
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).
This description comes directly from the study's public registry record.
Rebecca McNally Keehn, PhD, HSPP · 317-274-2121 · mcnallyr@iu.edu
Brandon Keehn, PhD · 765-496-0204 · bkeehn@purdue.edu
Always discuss trial participation with your own doctor first.
| Moi Teaching and Referral Hospital | Eldoret, Kenya | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06703125